2012 News Release Archive

 
12/26/2012
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients

National study connects higher rates of relapse in pediatric cancer patients to drug shortage, offering first example of patients hurt by shortages and renewing calls to protect patient access to lifesaving treatments. (Dr. Monika Metzger)

 
 
11/27/2012
Meyenburg Foundation honors Charles Mullighan of St. Jude Children’s Research Hospital for achievements in cancer research

Scientist at St. Jude is recipient of 2012 Meyenburg Cancer Research Award. (Dr. Charles Mullighan)

 
 
11/12/2012
Gene sequencing project identifies abnormal gene that launches rare childhood leukemia

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project discovery provides insight into a tough-to-cure form of acute myeloid leukemia that lays the groundwork for clinical care advances. (Dr. James Downing, Dr. Tanja Gruber)

 
 
10/23/2012
St. Jude Children’s Research Hospital image of blood-brain barrier wins photo competition

First image from a living animal wins 2012 Nikon Small World Competition that recognizes top photomicrographs from around the world. (Dr. Michael Taylor)

 
 
10/18/2012
Survivors Day Conference webcast focuses on late effects of childhood cancer therapy

St. Jude Children’s Research Hospital webcast offers childhood cancer survivors everywhere a chance to interact with experts and survivors about the risks and rewards of life after cancer. (St. Jude)

 
 
10/10/2012
St. Jude Children’s Research Hospital names new director of media relations

Gary M. Stephenson, former director of media relations and public affairs for Johns Hopkins Medicine, has joined St. Jude Children’s Research Hospital in Memphis, Tenn., as director of media relations.

 
 
10/01/2012
Pillai named 2012 V Scholar

Asha Pillai, MD, Bone Marrow Transplantation and Cellular Therapy, has been named a 2012 V Scholar in Cancer Research.

 
 
10/01/2012
St. Jude hosts world’s leading childhood cancer experts to talk about advances, the future of cancer research

On Thursday, October 4, and Friday, October 5, some of the world’s leading cancer scientists will discuss recent advances and the future of childhood cancer, as well as other life-threatening diseases. The experts represent the full spectrum of discovery, including basic science, clinical and translational research. It’s part of St. Jude Children’s Research Hospital’s 50th year Anniversary Biomedical Symposium. (St. Jude)

 
 
09/17/2012
Legacy bead program helps children and their families cope with life-threatening illnesses

At St. Jude Children’s Research Hospital, patients use beads to mark treatment milestones, from losing their hair to completing chemotherapy, in a program other hospitals could tailor to meet the needs of their patients. (St. Jude)

 
 
09/10/2012
Improved diagnostic test benefits children with acute myeloid leukemia

St. Jude Children’s Research Hospital study identifies the best test for determining treatment response in young leukemia patients, which could help guide therapy toward higher cure rate. (Dr. Hiroto Inaba)

 
 
09/04/2012
Gene sequencing project builds the foundation for next generation of childhood cancer care

September spotlights childhood cancer, which remains the leading cause of death by disease of young Americans. At St. Jude Children’s Research Hospital, doctors and scientists are working to change that statistic. (St. Jude)

 
 
08/31/2012
Intervention helps children with sickle cell disease complete MRI tests without sedation

St. Jude Children’s Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer. (Dr. Jane Hankins)

 
 
08/28/2012
Daily votes for St. Jude Children’s Research Hospital nurse can help win national contest

St. Jude Children’s Research Hospital nurse Ed Koen is a top-10 finalist in the national competition, The Amazing Nurses Contest.

 
 
08/13/2012
Existing drugs offer new treatment options for high-risk childhood leukemia subtype

Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer. (Charles Mullighan, MD)

 
 
08/10/2012
New regulatory mechanism discovered in cell system for eliminating unneeded proteins

Work led by St. Jude Children’s Research Hospital scientists offers clues into molecular malfunction at the heart of a rare blood vessel disorder, revealing an important new regulator of cellular proteins. (Brenda Schulman, PhD)

 
 
08/02/2012
Target for potent first-strike influenza drugs identified

St. Jude Children’s Research Hospital study shows how compounds blocking an enzyme universal to all influenza viruses may allow development of new antiviral drugs that also avoid the problem of drug resistance. (Dr. Stephen White)

 
 
07/02/2012
Innate immune system protein provides a new target in war against bacterial infections

Studies led by St. Jude Children’s Research Hospital show that a protein working on the frontlines of the immune response dampens inflammation and might offer a completely new approach to fighting bacterial infections. (Dr. Thirumala-Devi Kanneganti)

 
 
06/26/2012
Progress in quest to reduce use of radiation in treatment of pediatric Hodgkin lymphoma

Trial led by St. Jude Children’s Research Hospital investigators succeeds in keeping cure rates high for young patients with favorable-risk Hodgkin lymphoma while reducing their chances of serious treatment side effects. (Dr. Monika Metzger)

 
 
06/20/2012
Gene sequencing project identifies potential drug targets in common childhood brain tumor

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project lifts lid on the most aggressive subtype of medulloblastoma and finds genes that cooperate in tumor development. (Dr. Richard Gilbertson)

 
 
05/29/2012
World’s largest release of comprehensive human cancer genome data helps researchers everywhere speed discoveries

To speed progress against cancer and other diseases, the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project today announced the largest-ever release of comprehensive human cancer genome data for free access by the global scientific community. (Dr. James Downing)

 
 
04/30/2012
Key protein’s newly discovered form and function may provide novel cancer treatment target

St. Jude Children’s Research Hospital discovery that a protein vital for cell survival and immune balance has another form with a different function could yield additional cancer treatment strategy. (Dr. Joseph Opferman)

 
 
04/30/2012
Equal access to care helps close survival gap for young African-American cancer patients

St. Jude Children's Research Hospital closes survival gap for virtually all African-American and white children with cancer in a study that suggests equal access to care translates into an equal chance of a cure. (Dr. Ching-Hon Pui)

 
 
04/23/2012
Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor

St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer. (Dr. Peter McKinnon)

 
 
04/17/2012
Brenda Schulman, Ph.D., recognized as 2012 fellow of the American Academy of Arts and Sciences

Brenda Schulman, Ph.D., of St. Jude Children’s Research Hospital, has been named to the 2012 class of new Fellows and Foreign Honorary Members of the American Academy of Arts and Sciences (AAAS). Schulman was elected for her lab’s work on understanding a major form of cellular regulation, namely how ubiquitin-like proteins are conjugated to their target.

 
 
04/11/2012
Chemotherapy proves life-saving for some leukemia patients who fail induction therapy

An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction therapy. (Dr. Ching-Hon Pui)

 
 
03/20/2012
American Society of Clinical Oncology honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment

St. Jude Children’s Research Hospital physician is the recipient of the 2012 Pediatric Oncology Award.

 
 
03/13/2012
Genome sequencing initiative links altered gene to age-related neuroblastoma risk

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project and Memorial Sloan-Kettering Cancer Center discover first gene alteration associated with patient age and neuroblastoma outcome. (Dr. Michael Dyer)

 
 
03/12/2012
St. Jude Children’s Research Hospital CEO honored by the American Pharmacists Association for contributions to pharmacy field

William E. Evans, Pharm.D., is the recipient of the Remington Honor Medal, the pharmacy profession’s highest recognition

 
 
03/01/2012
Solving mystery of how sulfa drugs kill bacteria yields 21st century drug development target

St. Jude scientists discover key enzyme structure in bacteria, a finding that lays the foundation for a new generation of antibiotics that are safer and less prone to drug resistance. (Dr. Stephen White)

 
 
02/15/2012
The latest on drug shortages from St. Jude Children’s Research Hospital

Drug shortages have existed for several years, but they have recently intensified. (St. Jude)

 
 
01/30/2012
Inherited risk factors for childhood leukemia are more common in Hispanic patients

Results from a St. Jude Children’s Research Hospital and the Children’s Oncology Group study pinpoint genetic basis for increased leukemia risk facing Hispanic children and provide new hope for closing survival gap. (Dr. Jun Yang)

 
 
01/29/2012
Cancer sequencing initiative discovers mutations tied to aggressive childhood brain tumors

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project provides first evidence linking cancer to mutations in genes involved in DNA organization. (Dr. Suzanne Baker)

 
 
01/19/2012
St. Jude makes repeat appearance on FORTUNE magazine’s “100 Best Companies to Work For” list

St. Jude Children’s Research Hospital has been recognized by FORTUNE magazine as one of the “100 Best Companies to Work For” for the second consecutive year. (St. Jude)

 
 
01/11/2012
Cancer sequencing project identifies potential approaches to combat aggressive leukemia

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project discovers genetic connection linking two cancers that is likely to expand treatments for patients who currently have poor prognoses. (Dr. Charles Mullighan)

 
 
01/11/2012
St. Jude Children’s Research Hospital launches data website for genome project

Effort aims to accelerate pediatric cancer discoveries by sharing findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project. (St. Jude)

 
 
01/11/2012
Gene identified as a new target for treatment of aggressive childhood eye tumor

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project findings help solve mystery of retinoblastoma’s rapid growth in work that also yields a new treatment target and possible therapy. (Dr. Michael Dyer)